Catalyst Biosciences
Stock Forecast, Prediction & Price Target
Catalyst Biosciences Financial Estimates
Catalyst Biosciences Revenue Estimates
Catalyst Biosciences EBITDA Estimates
Catalyst Biosciences Earnings per Share Estimates
Passed | Analyst forecast | ||||||
---|---|---|---|---|---|---|---|
Metric | 12/31/2020 | 12/31/2021 | 12/31/2022 | 12/31/2025 | |||
Revenue
% change YoY
| $20.94M N/A | $7.33M -64.97% | $794K -89.17% | Avg: $3.17M Low: $3.17M High: $3.17M avg. 300% | |||
Net Income
% change YoY
| $-55.54M N/A | $-87.89M -58.24% | $-8.24M 90.62% | Avg: $-638K Low: $-630.91K High: $-630.91K avg. 92.25% | |||
EBITDA
% change YoY
| $-57.37M N/A | $-87.60M -52.70% | $-52.15M 40.46% | Avg: $-1.90M Low: $-1.90M High: $-1.90M avg. 96.34% | |||
EPS
% change YoY
| -$2.9 N/A | -$2.87 1.03% | -$0.26 90.94% | Avg: -$0.02 Low: -$0.02 High: -$0.02 avg. 92.30% | |||
Operating Expenses
% change YoY
| $69.15M N/A | $87.85M 27.03% | $30.40M -65.39% | Avg: $3.03M Low: $3.03M High: $3.03M avg. -90.02% |
FAQ
What is Catalyst Biosciences stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 92.25% in 2025-2025.
We have gathered data from 1 analysts. Their low estimate is -630.91K, average is -638K and high is -630.91K.
What is Catalyst Biosciences stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 300% in 2025-2025.
We have gathered data from N/A analysts. Their low revenue estimate is $3.17M, average is $3.17M and high is $3.17M.
What is Catalyst Biosciences stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 92.30% in 2025-2025.
We have gathered data from 1 analysts. Their low earnings per share estimate is -$0.02, average is -$0.02 and high is $-0.02.